PCK1 and hepatocellular carcinoma: Regarding the underlying mechanism, PCK1 deficiency can promote hepatoma cell proliferation by dis-regulating the AMPK/CDK/Rb/E2F pathway and accelerating transition of the hepatoma cell cycle from G1 to S phase [4].